Abstract
In the 19 years since the first CB transplantation was reported in the New England Journal of Medicine [9], the fields of CB research, banking and transplantation have flourished [2]. Umbilical CB has made allogeneic hematopoietic stem cell transplantation available to patients who do not have an HLA-identical sibling or an unrelated donor [20]. CB transplantation has been used to successfully treat leukemia, lymphoma, myelodysplasia, aplastic anemia, hemoglobinopathies, metabolic storage diseases, and immunodeficiencies. There are more than 300,000 unrelated CB units stored in 40 banks, and more than 10,000 CB transplants have been performed [20].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aktas M, Radke TF, Strauer BE et al (2008) Separation of adult bone marrow mononuclear cells using the automated closed separation system Sepax. Cytotherapy 10:203–211
Ballen KK, Barker JN, Stewart SK et al (2008) Collection and preservation of cord blood for personal use. Biol Blood Marrow Transplant 14:356–363
Barker JN, Weisdorf DJ, DeFor TE et al (2005) Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 105:1343–1347
Bieback K, Kern S, Kluter H et al (2004) Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 22:625–634
Brunstein CG, Barker JN, Weisdorf DJ et al (2007) Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood 110:3064–3070
Campagnoli C, Roberts IA, Kumar S et al (2001) Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98:2396–2402
Chan SL, Choi M, Wnendt S et al (2007) Enhanced in vivo homing of uncultured and selectively amplified cord blood CD34+ cells by cotransplantation with cord blood-derived unrestricted somatic stem cells. Stem Cells 25:529–536
Erices A, Conget P, Minguell JJ (2000) Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 109:235–242
Gluckman E, Broxmeyer HA, Auerbach AD et al (1989) Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 321:1174–1178
Goodwin HS, Bicknese AR, Chien SN et al (2001) Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers. Biol Blood Marrow Transplant 7:581–588
Greschat S, Schira J, Küry P et al (2008) Unrestricted somatic stem cells from human umbilical cord blood can be differentiated into neurons with a dopamineric phenotype. Stem Cells and Development (in press)
Huang GP, Pan ZJ, Jia BB et al (2007) Ex vivo expansion and transplantation of hematopoietic stem/progenitor cells supported by mesenchymal stem cells from human umbilical cord blood. Cell Transplant 16:579–585
Kern S, Eichler H, Stoeve J et al (2006) Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24:1294–1301
Kogler G, Callejas J, Hakenberg P et al (1996) Hematopoietic transplant potential of unrelated cord blood: critical issues. J Hematother 5:105–116
Kogler G, Sensken S, Airey JA et al (2004) A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 200:123–135
Kogler G, Radke TF, Lefort A et al (2005) Cytokine production and hematopoiesis supporting activity of cord blood-derived unrestricted somatic stem cells. Exp Hematol 33:573–583
Kogler G, Tutschek B, Koerschgen L et al (2005) Die José Carreras Stammzellbank Düsseldorf im NETCORD/EUROCORD-Verbund: Entwicklung, klinische Ergebnisse, Perspektiven und Aufklärung werdender Eltern. Gynäkologe 38:836–846
Kogler G, Sensken S, Wernet P (2006) Comparative generation and characterization of pluripotent unrestricted somatic stem cells with mesenchymal stem cells from human cord blood. Exp Hematol 34:1589–1595
Radke TF, Buchheiser A, Lefort A et al (2007) GMP-conform generation and cultivation of USSC from cord blood using the SEPAX-separation method and a closed culture system applying cell stacks. Blood 110(11):367
Rocha V, Gluckman E (2007) Outcomes of transplantation in children with acute leukaemia. Lancet 369:1906–1908
Sensken S, Waclawczyk S, Knaupp AS et al (2007) In vitro differentiation of human cord blood-derived unrestricted somatic stem cells towards an endodermal pathway. Cytotherapy 9:362–378
Sun W, Buzanska L, Domanska-Janik K et al (2005) Voltage-sensitive and ligand-gated channels in differentiating neural stem-like cells derived from the nonhematopoietic fraction of human umbilical cord blood. Stem Cells 23:931–945
Vaziri H, Dragowska W, Allsopp RC et al (1994) Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci U S A 91:9857–9860
Wang TT, Tio M, Lee W et al (2007) Neural differentiation of mesenchymal-like stem cells from cord blood is mediated by PKA. Biochem Biophys Res Commun 357:1021–1027
Wernet P, Callejas J, Enczmann J et al (1999) Osteoblast precursor cells derived from human umbilcal cord blood. Exp Hematol 27(Suppl 1):117
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kögler, G. (2009). The Unrestricted Somatic Stem Cell (USSC) From Cord Blood For Regenerative Medicine. In: Meyer, U., Handschel, J., Wiesmann, H., Meyer, T. (eds) Fundamentals of Tissue Engineering and Regenerative Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-77755-7_14
Download citation
DOI: https://doi.org/10.1007/978-3-540-77755-7_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-77754-0
Online ISBN: 978-3-540-77755-7
eBook Packages: MedicineMedicine (R0)